Print this pageP&T Committee meeting agenda's and requests for supplemental rebates are mailed/emailed 30 days prior to the meeting date.
If you would like to be added to the email list to receive these items, please contact Regina Chacon at (206) 521-2027.
View Evidence Based Drug Reviews
Proposed Drug Class Reviews (subject to change)
February 20, 2008
Agenda (35 KB) | Transcripts (444.8 KB)
New
Update
- Hormone Therapy (983.9 KB)
- ADHD final report (2.9 MB)
Scan
June 18, 2008
Agenda (31.9 KB) | Transcripts (276 KB)
Update
- Long Acting Opioids (706.2 KB)
Scan
- Ace Inhibitors (98 KB)
- Anti-Emetics (169.3 KB)
- Anti-Platelets (81.3 KB)
- Calcium Channel Blockers (156.3 KB)
- Insomnia drugs (76.6 KB)
- Skeletal Muscle Relaxants (67.9 KB)
- Triptans (79.9 KB)
August 20, 2008
Agenda (21 KB)
Update
- Atypical Antipsychotics (1.6 MB)
Scan
- MS, Drugs to Treat (127.5 KB)
- Over Active Bladder (85.6 KB)
- Proton Pump Inhibitors (366.1 KB)
October 15, 2008
New
- Newer Drugs to treat Diabetes
- Combination Diabetes Drugs
Update
- Nasal Corticosteroids
Scan
- Beta Blockers
- Thiazolidinediones (TZD)
- Oral Hypoglycemics
- Newer Antihistamines
December 17, 2008
New
- Topical Calcineurin Inhibitors
Update
- Beta Agonists
- Second Generation Antidepressants
Scan
- Hepatitis C
- Alzheimer’s, drugs to treat
2009
Supplemental Rebates
(DSHS - HRSA only)
Sealed bids should be mailed to:
Robin Arnold-Williams, Secretary
Department of Social and Health Services
P.O. Box 45010
14th & Jefferson Street
Olympia, WA 98504-5010
Faxes or electronic submissions will not be accepted. No bids will be entertained until the drug class is evaluated per the P&T Committee schedule. If you have questions about specific drugs that are included in these drug class reviews, please contact Siri Childs, Pharm D. with DSHS-HRSA at 360-725-1564.
If you are a person with a disability and need a special accommodation, please contact Regina Chacón 206-521-2027.
